Form 4 for STLN Starling Oncology, Inc.
Accepted 2025-11-19 00:00:00 ET · period of report 2025-11-17 · accession 0001079973-25-001807 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-19 | 2025-11-17 | STLN | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +2,086 | 237.9K | +0.9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-17 | A | A | 2,086 | $0.00 | 237,930 | D | — | — | (F1) Represents RSU awards that were fully vested upon grant, net of withholding tax obligations. |